Thromboreductin®


Capsule
scheduling status
S4
registration number
A39/8.5/0374
What Thromboreductin® contains
0,57 mg anagrelide hydrochloride equivalent to 0,5 mg anagrelide base.
other ingredients
Capsule contents: Lactose monohydrate Povidone K30 Crospovidone Microcrystalline cellulose Magnesium stearate Capsule shell: Titanium dioxide, E171 Indigo carmine, E132 Gelatin Water.
Therapeutic classification
L01XX35.
© 2026 SAHPRA. ALL RIGHTS RESERVED